# Mbia Inc: overview

MBI · NYSE · CIK 814585 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mbi.md) · [Financials](/companies/mbi/financials.md) · [Filings](/companies/mbi/filings.md) · [Insiders](/companies/mbi/insiders.md)

Latest reported revenue: [$27.0m](/filings/0001193125-26-338136.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-338136).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.0](/filings/0001193125-25-264782.md) | [37.0 d](/filings/0001193125-26-076834.md) | [14.0](/filings/0001193125-26-212078.md) | [23.0](/filings/0001193125-26-338136.md) | [15.0](/filings/0001193125-25-264782.md) | [28.0 d](/filings/0001193125-26-076834.md) | [24.0](/filings/0001193125-26-212078.md) | [27.0](/filings/0001193125-26-338136.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(193.1%)](/filings/0001193125-25-264782.md) | [2245.9% d](/filings/0001193125-26-076834.md) | [(442.9%)](/filings/0001193125-26-212078.md) | [(243.5%)](/filings/0000950170-25-104115.md) | [(53.3%)](/filings/0001193125-25-264782.md) | [(182.1%) d](/filings/0001193125-26-076834.md) | [(166.7%)](/filings/0001193125-26-212078.md) | [(159.3%)](/filings/0001193125-26-338136.md) |
| Diluted EPS | $ per share | [(1.18)](/filings/0001193125-25-264782.md) | not reported | [(1.28)](/filings/0001193125-26-212078.md) | [(1.12)](/filings/0001193125-26-338136.md) | [(0.17)](/filings/0001193125-25-264782.md) | not reported | [(0.80)](/filings/0001193125-26-212078.md) | [(0.91)](/filings/0001193125-26-338136.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [189](/filings/0000950170-24-022129.md) | [154](/filings/0000950170-25-029081.md) | [7.0](/filings/0001193125-26-076834.md) | [42.0](/filings/0001193125-26-076834.md) | [80.0](/filings/0001193125-26-076834.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(235.4%)](/filings/0000950170-24-022129.md) | [(126.6%)](/filings/0000950170-25-029081.md) | [6814.3%](/filings/0001193125-26-076834.md) | [1035.7%](/filings/0001193125-26-076834.md) | [(221.3%)](/filings/0001193125-26-076834.md) |
| Diluted EPS | $ per share | [(8.99)](/filings/0000950170-24-022129.md) | [(3.92)](/filings/0000950170-25-029081.md) | [(10.18)](/filings/0001193125-26-076834.md) | [(9.43)](/filings/0001193125-26-076834.md) | [(3.58)](/filings/0001193125-26-076834.md) |
| Free cash flow | $m | [510](/filings/0000950170-24-022129.md) | [(418)](/filings/0000950170-25-029081.md) | [(195)](/filings/0001193125-26-076834.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mbi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [KAHN BROTHERS GROUP INC](/funds/1039565.md) | 2026-06-30 | $27.5m | 4,213,920 |  | Added +2,157,486 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $23.9m | 3,673,151 |  | Added +280,169 |
| [Wolf Hill Capital Management, LP](/funds/1785988.md) | 2026-06-30 | $13.8m | 2,118,014 |  | Reduced −427,529 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $13.0m | 1,991,235 |  | Added +15,996 |
| [VALUEWORKS LLC](/funds/1282189.md) | 2026-06-30 | $12.8m | 1,967,228 |  | Added +35,338 |
| [Hosking Partners LLP](/funds/1650135.md) | 2026-06-30 | $10.1m | 1,549,265 |  | Reduced −35,648 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.4m | 1,142,258 |  | Added +55,737 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.1m | 1,092,959 |  | Added +24,206 |
| [Cerity Partners LLC](/funds/1566475.md) | 2026-06-30 | $7.1m | 1,087,425 |  | Added +655,209 |
| [TCW GROUP INC](/funds/850401.md) | 2026-06-30 | $6.9m | 1,065,260 |  | Added +26,800 |

## Recent filings

[All 1,152 filings](/companies/mbi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:26 ET | [10-Q](/filings/0001193125-26-338136.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338136 |
| 2026-08-06 | 16:20 ET | [8-K](/filings/0001193125-26-338100.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338100 |
| 2026-05-07 | 16:26 ET | [10-Q](/filings/0001193125-26-212078.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212078 |
| 2026-05-07 | 16:22 ET | [8-K](/filings/0001193125-26-212053.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-212053 |
| 2026-03-23 | 16:15 ET | [DEF 14A](/filings/0000814585-26-000048.md) | Proxy statement, period 2026-03-23 | 0000814585-26-000048 |
| 2026-02-26 | 16:40 ET | [8-K](/filings/0001193125-26-076968.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-076968 |
| 2026-02-26 | 16:26 ET | [10-K](/filings/0001193125-26-076834.md) | Annual report, period 2025-12-31 | 0001193125-26-076834 |
| 2025-11-04 | 16:26 ET | [10-Q](/filings/0001193125-25-264782.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264782 |
| 2025-11-04 | 16:20 ET | [8-K](/filings/0001193125-25-264751.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-25-264751 |
| 2025-08-19 | 16:15 ET | [8-K](/filings/0000950170-25-110108.md) | 8.01 Other events | 0000950170-25-110108 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076834.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/add61c4f-1a14-455c-b9b4-b42577f4c6e9)

## About the filer

- CIK: 814585
- Tickers: MBI
- Exchange: NYSE
- SIC code: 6351 Surety Insurance
- State of incorporation: CT
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.
